Long-term remission of subcutaneous panniculitis-like T-cell lymphoma with central nervous system involvement: A case report

被引:3
作者
Qiu, Yajuan [1 ]
Zhang, Dandan [2 ]
Zhang, Mingzhi [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Henan, Peoples R China
关键词
subcutaneous panniculitis-like T-cell lymphoma; central nervous system; lymphoma; treatment; NON-HODGKINS-LYMPHOMA; CUTANEOUS-LYMPHOMAS; PROGNOSTIC-FACTORS; EUROPEAN-ORGANIZATION; CNS LYMPHOMA; CLASSIFICATION; EORTC; FOTEMUSTINE; TENIPOSIDE; RITUXIMAB;
D O I
10.3892/ol.2016.4635
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an indolent cutaneous T-cell lymphoma with a favourable prognosis. The reported incidence of central nervous system (CNS) involvement in SPTCL is extremely low. SPTCL with CNS involvement is a fatal disease with no optimal treatment. The present study presents the case of a 27-year-old man who initially presented with erythematous nodules on the left buttock and left inguinal lymph node enlargement. A skin biopsy resulted in a diagnosis of SPTCL. Subsequent to diagnosis, the patient developed CNS involvement and underwent treatment of fotemustine, teniposide and dexamethasone, and complete remission was achieved for 78 months. To the best of our knowledge, this is the first case report of secondary CNS SPTCL with long-term remission. Accumulating evidence shows that this CNS-directed regimen can be effective in SPTCL with CNS involvement and in other CNS lymphomas.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 20 条
[1]   Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516-The Southwest Oncology Group [J].
Bernstein, Steven H. ;
Unger, Joseph M. ;
LeBlanc, Michael ;
Friedberg, Jonathan ;
Miller, Thomas P. ;
Fisher, Richard I. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) :114-119
[2]   Phase 2 Trial of High-Dose Rituximab With High-Dose Cytarabine Mobilization Therapy and High-Dose Thiotepa, Busulfan, and Cyclophosphamide Autologous Stem Cell Transplantation in Patients With Central Nervous System Involvement by Non-Hodgkin Lymphoma [J].
Chen, Yi-Bin ;
Batchelor, Tracy ;
Li, Shuli ;
Hochberg, Ephraim ;
Brezina, Mark ;
Jones, Sooae ;
Del Rio, Candice ;
Curtis, Morgan ;
Ballen, Karen K. ;
Barnes, Jeffrey ;
Chi, Andrew S. ;
Dietrich, Jorg ;
Driscoll, Jessica ;
Gertsner, Elizabeth R. ;
Hochberg, Fred ;
LaCasce, Ann S. ;
McAfee, Steven L. ;
Spitzer, Thomas R. ;
Nayak, Lakshmi ;
Armand, Philippe .
CANCER, 2015, 121 (02) :226-233
[3]   Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: A review of the literature [J].
Colocci, N ;
Glantz, M ;
Recht, L .
SEMINARS IN NEUROLOGY, 2004, 24 (04) :395-404
[4]   Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era? [J].
Deng, Lijuan ;
Song, Yuqin ;
Zhu, Jun ;
Zheng, Wen ;
Wang, Xiaopei ;
Xie, Yan ;
Lin, Ningjing ;
Tu, Meifeng ;
Ping, Lingyan ;
Ying, Zhitao ;
Liu, Weiping ;
Zhang, Chen .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) :664-671
[5]   Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma - A systematic analysis of 156 patients reported in the literature [J].
Go, RS ;
Wester, SM .
CANCER, 2004, 101 (06) :1404-1413
[6]   Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis [J].
Hollender, A ;
Kvaloy, S ;
Lote, K ;
Nome, O ;
Holte, H .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1762-1768
[7]   Glucocorticoid use in acute lymphoblastic leukaemia [J].
Inaba, Hiroto ;
Pui, Ching-Hon .
LANCET ONCOLOGY, 2010, 11 (11) :1096-1106
[8]   Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma-a long-term follow-up study (vol 23, pg 2670, 2012) [J].
Kasenda, B. ;
Schorb, E. ;
Fritsch, K. ;
Finke, J. ;
Illerhaus, G. .
ANNALS OF ONCOLOGY, 2015, 26 (03) :608-611
[9]   TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC) [J].
Kim, Youn H. ;
Willemze, Rein ;
Pimpinelli, Nicola ;
Whittaker, Sean ;
Olsens, Elise A. ;
Ranki, Annamari ;
Dummer, Reinhard ;
Hoppe, Richard T. .
BLOOD, 2007, 110 (02) :479-484
[10]  
MACKINTOSH FR, 1982, CANCER-AM CANCER SOC, V49, P586, DOI 10.1002/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO